Advertisement

Pediatric Cardiology

, Volume 37, Issue 7, pp 1313–1318 | Cite as

Body Mass Index (BMI) is Associated with the Therapeutic Response to Oral Rehydration Solution in Children with Postural Tachycardia Syndrome

  • Hongxia Li
  • Yuli Wang
  • Ping Liu
  • Yonghong Chen
  • Xueli Feng
  • Chaoshu Tang
  • Junbao Du
  • Hongfang Jin
Original Article

Abstract

We aimed to explore whether the body mass index (BMI) was associated with the therapeutic response to oral rehydration solution (ORS) in children with postural tachycardia syndrome (POTS). Fifty-four children diagnosed as having POTS were included in this study. Fifty-six healthy children served as the controls. Children with POTS were treated with ORS, and their treatment response was evaluated. The baseline BMI was obtained by measuring the height and weight. The Pearson correlation was made between the baseline BMI and change in heart rate from supine to upright (ΔHR) and between baseline BMI and symptom score change (post-treatment vs. pre-treatment) in the POTS group. The value of BMI in predicting the therapeutic response to ORS was assessed by analyses of the receiver operating characteristic (ROC) curve. The BMI in the POTS group was significantly lower than that in the control group (18.22 ± 3.23 vs. 20.62 ± 3.05 kg/m2, p < 0.01). There were no statistical differences between responders and non-responders in symptom scores before treatment (p > 0.05), but symptom score was lower in responders than that in non-responders (1.52 ± 0.95 vs. 2.32 ± 1.22, p < 0.01) after treatment. The BMI in responders to ORS was significantly lower than that of non-responders (16.32 ± 2.28 vs. 20.43 ± 2.74 kg/m2, p < 0.01). The BMI was correlated negatively with ΔHR in the POTS group (n = 54, r = −0.766, p < 0.01) and with the decrease in symptom scores after treatment in POTS patients (n = 54, r = −0.28, p < 0.05). ROC curve revealed the area under the curve to be 92.3 % (95 % confidence interval 0.829–0.996). A cutoff value of the BMI of 18.02 kg/m2 had high sensitivity (92 %) and high specificity (82.8 %) for predicting the effect of ORS treatment for POTS. BMI is associated with the therapeutic response to ORS in children with POTS.

Keywords

Postural tachycardia syndrome Orthostatic intolerance Body mass index Oral rehydration solution Heart rate Blood pressure 

Abbreviations

AUC

Area under the curve

BMI

Body mass index

BP

Blood pressure

DBP

Diastolic blood pressure

ECG

Electrocardiogram

HR

Heart rate

HUTT

Head-up tilt test

ORS

Oral rehydration solution

POTS

Postural tachycardia syndrome

ROC

Receiver operating characteristic curve

SBP

Systolic blood pressure

Notes

Acknowledgments

The work was supported by Grants from the National Twelfth Five-Year Plan for Science and Technology Support (2012BAI03B03) and the National Natural Science Foundation of China (81121061).

Author Contributions

CT, HJ, JD, and HL designed the research; CT, JD, HL, PL, XF, YC, HJ, and YW participated in the acquisition of the data; HL, YW, PL, and YC analyzed the data; HL, HJ, YW, PL, YC, XF, CT, and JD interpreted the results of the experiments; HL, YW, HJ, and JD drafted the manuscript; HL, HJ, and JD revised the manuscript. All the authors have read and approved the final manuscript.

Compliance with Ethical Standards

Conflict of interest

None declared.

References

  1. 1.
    Zhang F, Li X, Stella C, Chen L, Liao Y, Tang C, Jin H, Du J (2012) Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children. J Pediatr 160:227–231. doi: 10.1016/j.jpeds.2011.08.008 CrossRefPubMedGoogle Scholar
  2. 2.
    Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, Haythornthwaite JA, Low PA (2002) Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc 77:531–537CrossRefPubMedGoogle Scholar
  3. 3.
    Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, Du J (2011) Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J 75:927–931CrossRefPubMedGoogle Scholar
  4. 4.
    Zhang Q, Liao Y, Tang C, Du J, Jin H (2012) Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr 161:281–284. doi: 10.1016/j.jpeds.2012.01.054 CrossRefPubMedGoogle Scholar
  5. 5.
    Steward JM (2004) Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS). J Pediatr 145:725–730CrossRefGoogle Scholar
  6. 6.
    Raj SR, Robertson D (2007) Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci 334:57–60CrossRefPubMedGoogle Scholar
  7. 7.
    Ojha A, Chelimsky TC, Chelimsky G (2011) Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr 158:20–23. doi: 10.1016/j.jpeds.2010.07.005 CrossRefPubMedGoogle Scholar
  8. 8.
    Medow MS, Minson CT, Stewart III (2005) Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Cirulation 112:2611–2618CrossRefGoogle Scholar
  9. 9.
    Liao Y, Chen S, Liu X, Zhang Q, Ai Y, Wang Y, Jin H, Tang C, Du J (2010) Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol 106:378–382. doi: 10.1016/j.amjcard.2010.03.034 CrossRefPubMedGoogle Scholar
  10. 10.
    Stewart JM, Medow MS, Montgomery LD, McLeod K (2004) Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow. Am J Physiol Heart Circ Physiol 286:H1216–H1222CrossRefPubMedGoogle Scholar
  11. 11.
    Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541–549CrossRefPubMedGoogle Scholar
  12. 12.
    Johnson JN, Mack KJ, Kuntz NL, Brands CK, Porter CJ, Fischer PR (2010) Postural orthostatic tachycardia syndrome: a clinical review. Pediatr Neurol 42:77–85. doi: 10.1016/j.pediatrneurol.2009.07.002 CrossRefPubMedGoogle Scholar
  13. 13.
    Tanaka H, Fujita Y, Takenaka Y et al (2009) Task force of clinical guidelines for child orthostatic dysregulation, Japanese Society of Psychosomatic Pediatrics. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int 51:169–179. doi: 10.1111/j.1442-200X.2008.02783.x CrossRefPubMedGoogle Scholar
  14. 14.
    Medow MS, Stewart JM (2007) The postural tachycardia syndrome. Cardiol Rev 15:67–75CrossRefPubMedGoogle Scholar
  15. 15.
    Stewart JM, Taneja I, Medow MS (2007) Reduced body mass index is associated with increased angiotensin II in young women with postural tachycardia syndrome. Clin Sci (Lond) 113:449–457CrossRefGoogle Scholar
  16. 16.
    Singer M, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA (2012) Postural tachycardia in children and adolescents: what is abnormal? J Pediatr 160:222–226. doi: 10.1016/j.jpeds.2011.08.054 Epub 2011 Oct 11 CrossRefPubMedGoogle Scholar
  17. 17.
    Raj SR (2006) The postural tachycardia syndrome (postural tachycardia syndrome): pathophysiology, diagnosis, and management. Indian Pacing Electrophysiol J 6:84–89PubMedPubMedCentralGoogle Scholar
  18. 18.
    Winder R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson D, Diedrich A, Maier R, Pilger A, Haber P, Rüdiger HW (2005) Endurance exercise training in orthostatic intolerance: a randomized controlled trial. Hypertension 45:391–398CrossRefGoogle Scholar
  19. 19.
    Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, Jin H, Du J (2012) Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol 24:315–320. doi: 10.1016/j.jacc.2012.04.025 CrossRefGoogle Scholar
  20. 20.
    Jarhour IT (2013) Postural tachycardia syndrome in children and adolescents. Semin Pediatr Neurol 20:18–26. doi: 10.1016/j.spen.2013.01.001 CrossRefGoogle Scholar
  21. 21.
    Chen L, Li X, Todd O, Wang C, Jin H, Du J (2013) A clinical manifestation-based prediction of haemodynamic patterns of orthostatic intolerance in children: a multi-centre study. Cardiol Young 18:1–5. doi: 10.1017/S1047951113000929 Google Scholar
  22. 22.
    Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R (2011) Postural tachycardia syndrome—current experience and concepts. Nat Rev Neurol 8:22–34. doi: 10.1038/nrneurol.2011.187 CrossRefPubMedGoogle Scholar
  23. 23.
    Yang J, Zhao J, Du S, Liu D, Fu C, Li X, Chen S, Tang C, Du J, Jin H (2013) Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. J Pediatr 163:1169–1173. doi: 10.1016/j.jpeds.2013.04.039 CrossRefPubMedGoogle Scholar
  24. 24.
    Mack KJ, Johnson JN, Rowe PC (2010) Orthostatic intolerance and the headache patient. Semin Pediatr Neurol 17:109–116. doi: 10.1016/j.spen.2010.04.006 CrossRefPubMedGoogle Scholar
  25. 25.
    Low PA, Sandroni P, Joyner M, Shen WK (2009) Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 20:352–358. doi: 10.1111/j.1540-8167.2008.01407.x CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Winker R (2004) Orthostatic intolerance—prevalence, diagnostic management and its significance for occupational medicine. Wien Klin Wochenschr 116(Suppl 1):40–46PubMedGoogle Scholar
  27. 27.
    Grubb BP, Kanjwal YK, Osinski DJ (2006) The postural tachycardia syndrome: a concise guide to diagnosis and treatment. J Cardiovasc Electrophysiol 17:108–112CrossRefPubMedGoogle Scholar
  28. 28.
    Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA (2007) Postural tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc 82:308–313CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Hongxia Li
    • 1
  • Yuli Wang
    • 1
  • Ping Liu
    • 1
  • Yonghong Chen
    • 1
  • Xueli Feng
    • 1
  • Chaoshu Tang
    • 2
  • Junbao Du
    • 1
    • 3
  • Hongfang Jin
    • 1
  1. 1.Department of PediatricsPeking University First HospitalBeijingPeople’s Republic of China
  2. 2.Department of Physiology and PathophysiologyPeking University Health Sciences CentreBeijingPeople’s Republic of China
  3. 3.Key Laboratory of Cardiovascular ScienceMinistry of EducationBeijingPeople’s Republic of China

Personalised recommendations